ANOAX
Price
$21.67
Change
-$0.40 (-1.81%)
Updated
Jun 10 closing price
Net Assets
5.38B
VSGAX
Price
$118.95
Change
-$2.14 (-1.77%)
Updated
Jun 10 closing price
Net Assets
45.54B
Interact to see
Advertisement

ANOAX vs VSGAX

Header iconANOAX vs VSGAX Comparison
Open Charts ANOAX vs VSGAXBanner chart's image
ANOAX vs VSGAX Comparison Chart in %
View a ticker or compare two or three
VS
ANOAX vs. VSGAX commentary
Jun 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANOAX is a Hold and VSGAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGAX has more cash in the bank: 45.5B vs. ANOAX (5.38B). VSGAX pays higher dividends than ANOAX: VSGAX (0.44) vs ANOAX (0.00). ANOAX was incepted earlier than VSGAX: ANOAX (23 years) vs VSGAX (15 years). ANOAX (1.38) is less costly to investors than VSGAX (0.07). ANOAX is a more actively managed with annual turnover of: 90.00 vs. VSGAX (24.00). ANOAX has a lower initial minimum investment than VSGAX: ANOAX (2500) vs VSGAX (3000). VSGAX annual gain was more profitable for investors over the last year : 26.25 vs. ANOAX (9.69). VSGAX return over 5 years is better than : 21.92 vs. ANOAX (-10.43).
ANOAXVSGAXANOAX / VSGAX
Total Expense Ratio1.380.071,971%
Annual Report Gross Expense Ratio1.380.071,971%
Fund Existence23 years15 years-
Gain YTD10.29514.14373%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets5.38B45.5B12%
Annual Yield % from dividends0.000.44-
Returns for 1 year9.6926.2537%
Returns for 3 years35.9855.5165%
Returns for 5 years-10.4321.92-48%
Returns for 10 years78.99183.7143%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CODX4.880.38
+8.44%
Co-Diagnostics Inc.
LZ5.860.25
+4.46%
LegalZoom.com
COR281.241.67
+0.60%
Cencora
MTH70.56-1.53
-2.12%
Meritage Homes Corporation
LENZ6.59-0.20
-2.95%
LENZ Therapeutics